RecruitingNot ApplicableNCT03506893

Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients


Sponsor

University Hospital, Grenoble

Enrollment

90 participants

Start Date

Jul 17, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

The hypothesis is that the Alfapump® strategy would be more effective in terms of QALYs generated , and that the cost of Alfapump® device and its implantation will be totally or partially offset by the reduction in the number of evacuating parentheses performed and the reduction in the number of complications in patients with refractory ascites awaiting liver transplantation or not. On the other hand, given the difference in the clinical profiles of these two populations (whether or not they are awaiting transplantation), these two populations will be study separately Evaluation of the medical-economic impact at 1 year of the two therapeutic strategies: implantation of Alfapump® versus repeated evacuating paracentesis in cirrhotic patients with refractory ascites without scheduled liver transplantation.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Alphapump and a procedure called Ascites puncture for people with ascites, cirrhosis, and other related conditions. The study is currently recruiting participants at 10 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAlphapump

Alfapump® device: a completely internalized medical device, implanted under the skin, which mobilizes ascites from the peritoneal cavity to the bladder where they are eliminated by the urinary tract. Medical device marked CE, used in the indication provided for marking

PROCEDUREAscites puncture

Hospitalizations for evacuating ascites are performed at least twice a month and can be up to 2 times a week. A clinical and biological examination is carried out at each visit.


Locations(10)

Amiens-Picardie University Hospital

Amiens, France

Chu Angers

Angers, France

Jean MINJOZ Univesity Hospital

Besançon, France

Haut-Lévêque Hospital

Bordeaux, France

Beaujon Hospital

Clichy, France

Grenoble University Hospital

Grenoble, France

LA PITIE SALPETRIERE Univesity Hospital

Paris, France

Chu Poitiers

Poitiers, France

Chu Pontchaillou

Rennes, France

Toulouse University Hospital

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03506893


Related Trials